Entegris Reports Results for Fourth Quarter of 2025
- Net sales of $824 million.
-
GAAP diluted EPS of
$0.32 . -
Non-GAAP diluted EPS of
$0.70 .
Quarterly Financial Results Summary
(in millions, except percentages and per share data)
|
GAAP Results |
|
|
|
|
Net sales |
|
|
|
|
Gross margin - as a % of net sales |
43.8% |
45.6% |
43.5% |
|
Operating margin - as a % of net sales |
12.7% |
17.7% |
15.2% |
|
Net income |
|
|
|
|
Diluted earnings per common share |
|
|
|
|
|
|
|
|
|
Non-GAAP Results |
|
|
|
|
Adjusted gross margin - as a % of net sales |
44.0% |
45.6% |
43.6% |
|
Adjusted operating margin - as a % of net sales |
21.2% |
23.5% |
21.1% |
|
Adjusted EBITDA - as a % of net sales |
27.7% |
29.2% |
27.3% |
|
Diluted non-GAAP earnings per common share |
|
|
|
First Quarter of 2026 Outlook
For the Company’s guidance for the first quarter ending
Segment Results
The Company currently operates in two segments:
Materials Solutions (MS): MS provides materials-based solutions, such as chemical vapor and atomic layer deposition materials, chemical mechanical planarization slurries and pads, ion implantation specialty gases, formulated etch and clean materials, and other specialty materials that enable our customers to achieve better device performance and faster time to yield, while providing for lower total cost of ownership.
Advanced Purity Solutions (APS): APS offers filtration, purification and contamination-control solutions that improve customers’ yield, device reliability and cost by ensuring the purity of critical liquid chemistries and gases and the cleanliness of wafers and other substrates used throughout semiconductor manufacturing processes, the semiconductor ecosystem and other high-technology industries.
Fourth Quarter Results Conference Call
Entegris will hold a conference call to discuss its results for the fourth quarter on
Management’s slide presentation concerning the results for the fourth quarter will be posted on the Investor Relationssection of www.entegris.com.
About Entegris
Entegris is a leading supplier of critical advanced materials and process solutions for the semiconductor and other high-technology industries. Entegris has approximately 7,700 employees throughout its global operations and is ISO 9001 certified. It has manufacturing, customer service and/or research facilities in
Non-GAAP Information
The Company’s condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in
Cautionary Note on Forward-Looking Statements
This news release contains “forward-looking statements.” The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “forecast,” “project,” “should,” “may,” “will,” “would” or the negative thereof and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are based on current management expectations and assumptions only as of the date of this news release. They are not guarantees of future performance and they involve substantial risks and uncertainties that are difficult to predict and that could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, but are not limited to, fluctuations in the demand for semiconductors; the impact of global economic uncertainty, including volatile financial markets, inflationary pressures and interest rate fluctuations, economic recessions, national debt and bank failures, raw material shortages, supply constraints, and price increases; supply chain interruptions and the Company’s dependence on sole, single and limited source suppliers; operational, political and legal risks associated with the Company’s international operations, including those related to geopolitical uncertainty and regional and global instabilities and hostilities, including, but not limited to, the ongoing conflicts between
|
Condensed Consolidated Statements of Operations (In millions, except per share data) (Unaudited) |
||||
|
|
|
Three months ended |
||
|
|
|
|
|
|
|
Net sales |
|
|
|
|
|
Cost of sales |
463.3 |
462.5 |
455.8 |
|
|
Gross profit |
360.6 |
387.3 |
351.3 |
|
|
Selling, general and administrative expenses |
130.4 |
109.6 |
101.8 |
|
|
Engineering, research and development expenses |
79.0 |
81.5 |
80.9 |
|
|
Amortization of intangible assets |
46.3 |
46.2 |
46.0 |
|
|
Operating income |
104.9 |
150.0 |
122.6 |
|
|
Interest expense, net |
45.7 |
50.6 |
46.1 |
|
|
Other expense (income), net |
4.1 |
(13.1) |
4.2 |
|
|
Income before income tax expense |
55.1 |
112.5 |
72.3 |
|
|
Income tax expense |
5.5 |
10.0 |
1.5 |
|
|
Equity in net loss of affiliates |
0.2 |
0.2 |
0.3 |
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per common share |
|
|
|
|
|
Diluted earnings per common share |
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding: |
|
|
|
|
|
Basic |
151.9 |
151.2 |
151.8 |
|
|
Diluted |
152.5 |
151.9 |
152.3 |
|
|
Condensed Consolidated Statements of Operations (In millions, except per share data) (Unaudited) |
|||
|
|
|
Twelve months ended |
|
|
|
|
|
|
|
Net sales |
|
|
|
|
Cost of sales |
1,776.7 |
1,754.5 |
|
|
Gross profit |
1,419.9 |
1,486.7 |
|
|
Selling, general and administrative expenses |
450.6 |
446.6 |
|
|
Engineering, research and development expenses |
329.0 |
316.1 |
|
|
Amortization of intangible assets |
184.4 |
190.1 |
|
|
Operating income |
455.9 |
533.9 |
|
|
Interest expense, net |
191.9 |
207.9 |
|
|
Other expense, net |
9.4 |
4.0 |
|
|
Income before income tax expense |
254.6 |
322.0 |
|
|
Income tax expense |
18.0 |
28.3 |
|
|
Equity in net loss of affiliates |
1.0 |
0.9 |
|
|
Net income |
|
|
|
|
|
|
|
|
|
Basic earnings per common share: |
|
|
|
|
Diluted earnings per common share: |
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding: |
|
|
|
|
Basic |
151.7 |
150.9 |
|
|
Diluted |
152.2 |
151.8 |
|
|
Condensed Consolidated Balance Sheets (In millions) (Unaudited) |
||
|
|
|
|
|
ASSETS |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
|
|
|
Trade accounts and notes receivable, net |
458.7 |
495.3 |
|
Inventories, net |
643.2 |
638.1 |
|
Deferred tax charges and refundable income taxes |
35.1 |
39.6 |
|
Assets held-for-sale |
— |
5.5 |
|
Other current assets |
140.8 |
108.6 |
|
Total current assets |
1,638.2 |
1,616.3 |
|
Property, plant and equipment, net |
1,636.1 |
1,622.9 |
|
Right-of-use assets |
108.7 |
83.4 |
|
|
3,946.7 |
3,943.6 |
|
Intangible assets, net |
906.9 |
1,091.7 |
|
Deferred tax assets and other noncurrent tax assets |
91.6 |
12.5 |
|
Other noncurrent assets |
22.3 |
24.2 |
|
Total assets |
|
|
|
LIABILITIES AND EQUITY |
|
|
|
Current liabilities |
|
|
|
Accounts payable |
|
|
|
Accrued liabilities |
234.7 |
250.2 |
|
Liabilities held-for-sale |
— |
1.2 |
|
Income taxes payable |
82.4 |
80.5 |
|
Total current liabilities |
488.6 |
525.2 |
|
Long-term debt |
3,697.6 |
3,981.1 |
|
Long-term lease liabilities |
98.6 |
72.1 |
|
Other liabilities |
112.3 |
124.7 |
|
Shareholders’ equity |
3,953.4 |
3,691.5 |
|
Total liabilities and equity |
|
|
|
Condensed Consolidated Statements of Cash Flows (In millions) (Unaudited) |
||||
|
|
Three months ended |
Twelve months ended |
||
|
|
|
|
|
|
|
Operating activities: |
|
|
|
|
|
Net income |
|
|
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
Depreciation |
53.7 |
48.3 |
205.3 |
188.1 |
|
Amortization |
46.3 |
46.2 |
184.4 |
190.1 |
|
Share-based compensation expense |
18.9 |
15.6 |
69.3 |
65.9 |
|
Provision for deferred income taxes |
(32.6) |
(31.8) |
(87.4) |
(78.9) |
|
Other |
38.7 |
16.7 |
95.5 |
82.6 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
Trade accounts and notes receivable |
32.8 |
3.1 |
40.3 |
(49.0) |
|
Inventories |
(8.7) |
(7.9) |
(43.1) |
(76.7) |
|
Accounts payable and accrued liabilities |
(22.5) |
(43.7) |
12.0 |
8.9 |
|
Income taxes payable and refundable income taxes |
33.9 |
31.6 |
(7.6) |
7.9 |
|
Other |
(17.9) |
(4.3) |
(8.9) |
— |
|
Net cash provided by operating activities |
192.0 |
176.1 |
695.4 |
631.7 |
|
Investing activities: |
|
|
|
|
|
Acquisition of property, plant and equipment |
(58.0) |
(107.5) |
(299.2) |
(315.6) |
|
Proceeds from government incentives |
— |
— |
8.2 |
— |
|
Proceeds from sale of business, net |
(6.7) |
— |
(6.7) |
250.8 |
|
Other |
(1.6) |
(0.4) |
(3.1) |
(2.3) |
|
Net cash used in investing activities |
(66.3) |
(107.9) |
(300.8) |
(67.1) |
|
Financing activities: |
|
|
|
|
|
Proceeds from debt |
35.0 |
110.0 |
567.0 |
364.5 |
|
Payments of debt |
(185.0) |
(260.0) |
(867.0) |
(988.3) |
|
Payments for dividends |
(15.1) |
(15.1) |
(60.8) |
(60.6) |
|
Issuance of common stock |
3.1 |
0.4 |
6.7 |
14.0 |
|
Taxes paid related to net share settlement of equity awards |
(0.2) |
(0.8) |
(10.8) |
(16.9) |
|
Other |
(0.6) |
0.2 |
(2.0) |
(1.6) |
|
Net cash used in financing activities |
(162.8) |
(165.3) |
(366.9) |
(688.9) |
|
Effect of exchange rate changes on cash and cash equivalents |
(2.3) |
(5.8) |
3.5 |
(3.4) |
|
(Decrease) increase in cash and cash equivalents |
(39.4) |
(102.9) |
31.2 |
(127.7) |
|
Cash and cash equivalents at beginning of period |
399.8 |
432.1 |
329.2 |
456.9 |
|
Cash and cash equivalents at end of period |
|
|
|
|
|
Segment Information (In millions) (Unaudited) |
|||||
|
|
Three months ended |
Twelve months ended |
|||
|
Net sales |
|
|
|
|
|
|
Materials Solutions |
|
|
|
|
|
|
Advanced Purity Solutions |
464.5 |
491.2 |
460.8 |
1,799.1 |
1,850.2 |
|
Inter-segment elimination |
(2.4) |
(2.5) |
(2.3) |
(9.2) |
(9.1) |
|
Total net sales |
|
|
|
|
|
|
|
Three months ended |
Twelve months ended |
|||
|
Segment profit |
|
|
|
|
|
|
Materials Solutions |
|
|
|
|
|
|
Advanced Purity Solutions |
104.2 |
134.9 |
118.2 |
426.4 |
496.1 |
|
Total segment profit |
168.1 |
212.0 |
183.4 |
703.0 |
782.3 |
|
Amortization of intangibles |
(46.3) |
(46.2) |
(46.0) |
(184.4) |
(190.1) |
|
Unallocated expenses |
(16.9) |
(15.8) |
(14.8) |
(62.7) |
(58.3) |
|
Total operating income |
|
|
|
|
|
|
Reconciliation of GAAP Gross Profit to Adjusted Gross Profit (In millions) (Unaudited) |
|||||
|
|
Three months ended |
Twelve months ended |
|||
|
|
|
|
|
|
|
|
Net sales |
|
|
|
|
|
|
Gross profit-GAAP |
|
|
|
|
|
|
Adjustments to gross profit: |
|
|
|
|
|
|
Restructuring costs 1 |
1.7 |
0.4 |
0.3 |
4.3 |
0.4 |
|
Adjusted gross profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin - as a % of net sales |
43.8 % |
45.6 % |
43.5 % |
44.4 % |
45.9 % |
|
Adjusted gross margin - as a % of net sales |
44.0 % |
45.6 % |
43.6 % |
44.6 % |
45.9 % |
|
1 Restructuring charges resulting from discrete cost saving initiatives inclusive of employee termination benefit and asset impairment charges, primarily related to (i) an internal reorganization, combining two complementary divisions into one and realigning our customer facing organization and (ii) workforce reductions, contract termination costs and the abandonment of certain capital equipment no longer necessary for the Company’s long-term objectives. |
|||||
|
Reconciliation of GAAP Segment Profit to Adjusted Operating Income (In millions) (Unaudited) |
|||||
|
|
Three months ended |
Twelve months ended |
|||
|
Adjusted segment profit |
|
|
|
|
|
|
MS segment profit |
|
|
|
|
|
|
Restructuring costs 1 |
0.9 |
1.1 |
0.7 |
4.7 |
1.1 |
|
Loss (gain) on sale of businesses 2 |
10.9 |
— |
— |
10.9 |
(4.3) |
|
Impairment of long-lived assets 3 |
— |
— |
— |
— |
13.0 |
|
MS adjusted segment profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
APS segment profit |
|
|
|
|
|
|
Restructuring costs 1 |
10.8 |
2.2 |
1.0 |
24.0 |
2.2 |
|
APS adjusted segment profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
Unallocated general and administrative expenses |
|
|
|
|
|
|
Less: unallocated deal and integration costs |
— |
— |
— |
— |
(3.4) |
|
Less: unallocated restructuring costs 1 |
(0.6) |
(0.6) |
— |
(1.0) |
(0.6) |
|
Less: unallocated acquired tax equalization asset reduction 4 |
— |
— |
— |
— |
(3.0) |
|
Adjusted unallocated general and administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total adjusted segment profit |
|
|
|
|
|
|
Less: adjusted unallocated general and administrative expenses |
(16.3) |
(15.2) |
(14.8) |
(61.7) |
(51.3) |
|
Total adjusted operating income |
|
|
|
|
|
|
1 Restructuring charges resulting from discrete cost saving initiatives inclusive of employee termination benefit and asset impairment charges, primarily related to (i) an internal reorganization, combining two complementary divisions into one and realigning our customer facing organization and (ii) workforce reductions, contract termination costs and the abandonment of certain capital equipment no longer necessary for the Company’s long-term objectives. 2 Loss (gain) from the sale of certain of the Company’s PIM and small, industrial specialty chemicals businesses. 3 Impairment of long-lived assets related to a small, industrial specialty chemicals business.
4 Represents an asset reduction of an acquired tax equalization asset from the |
|||||
|
Reconciliation of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA (In millions) (Unaudited) |
|||||
|
|
Three months ended |
Twelve months ended |
|||
|
|
|
|
|
|
|
|
Net sales |
|
|
|
|
|
|
Net income |
|
|
|
|
|
|
Net income - as a % of net sales |
6.0% |
12.0% |
8.7% |
7.4% |
9.0% |
|
Adjustments to net income: |
|
|
|
|
|
|
Equity in net loss of affiliates |
0.2 |
0.2 |
0.3 |
1.0 |
0.9 |
|
Income tax expense |
5.5 |
10.0 |
1.5 |
18.0 |
28.3 |
|
Interest expense, net |
45.7 |
50.6 |
46.1 |
191.9 |
207.9 |
|
Other expense (income), net |
4.1 |
(13.1) |
4.2 |
9.4 |
4.0 |
|
GAAP - Operating income |
104.9 |
150.0 |
122.6 |
455.9 |
533.9 |
|
Operating margin - as a % of net sales |
12.7% |
17.7% |
15.2% |
14.3% |
16.5% |
|
Integration costs: |
|
|
|
|
|
|
Professional fees 1 |
— |
— |
— |
— |
2.6 |
|
Severance costs 2 |
— |
— |
— |
— |
0.8 |
|
Restructuring costs 3 |
12.3 |
3.9 |
1.7 |
29.7 |
3.9 |
|
Acquired tax equalization asset reduction 4 |
— |
— |
— |
— |
3.0 |
|
Loss (gain) on sale of businesses 5 |
10.9 |
— |
— |
10.9 |
(4.3) |
|
Impairment of long-lived assets 6 |
— |
— |
— |
— |
13.0 |
|
Amortization of intangible assets 7 |
46.3 |
46.2 |
46.0 |
184.4 |
190.1 |
|
Adjusted operating income |
174.4 |
200.1 |
170.3 |
680.9 |
743.0 |
|
Adjusted operating margin - as a % of net sales |
21.2% |
23.5% |
21.1% |
21.3% |
22.9% |
|
Depreciation |
53.7 |
48.3 |
50.4 |
205.3 |
188.1 |
|
Adjusted EBITDA |
|
|
|
|
|
|
Adjusted EBITDA - as a % of net sales |
27.7% |
29.2% |
27.3% |
27.7% |
28.7% |
|
1 Represents professional and vendor fees recorded in connection with services provided by consultants, accountants, lawyers and
other third-party service providers to assist us in integrating
2 Represents severance charges related to the integration of 3 Restructuring charges resulting from discrete cost saving initiatives inclusive of employee termination benefit and asset impairment charges, primarily related to (i) an internal reorganization, combining two complementary divisions into one and realigning our customer facing organization and (ii) workforce reductions, contract termination costs and the abandonment of certain capital equipment no longer necessary for the Company’s long-term objectives.
4 Represents an asset reduction of an acquired tax equalization asset from the 5 Loss (gain) from the sale of certain of the Company’s PIM and small, industrial specialty chemicals businesses. 6 Impairment of long-lived assets related to a small, industrial specialty chemicals business. 7 Non-cash amortization expense associated with intangibles acquired in acquisitions. |
|||||
|
Reconciliation of GAAP Net Income and Diluted Earnings per Common Share to Non-GAAP Net Income and Diluted Non-GAAP Earnings per Common Share (In millions, except per share data) (Unaudited) |
|||||
|
|
Three months ended |
Twelve months ended |
|||
|
|
|
|
|
|
|
|
GAAP net income |
|
|
|
|
|
|
Adjustments to net income: |
|
|
|
|
|
|
Integration costs: |
|
|
|
|
|
|
Professional fees 1 |
— |
— |
— |
— |
2.6 |
|
Severance costs 2 |
— |
— |
— |
— |
0.8 |
|
Restructuring costs 3 |
12.3 |
3.9 |
1.7 |
29.7 |
3.9 |
|
Patent infringement settlement gain, net 4 |
— |
(20.0) |
— |
— |
(20.0) |
|
Acquired tax equalization asset reduction 5 |
— |
— |
— |
— |
3.0 |
|
Loss on extinguishment of debt and modification 6 |
1.5 |
2.0 |
1.7 |
3.2 |
14.3 |
|
Loss (gain) on sale of businesses 7 |
10.9 |
— |
— |
10.9 |
(4.3) |
|
Impairment of long-lived assets 8 |
— |
— |
— |
— |
13.0 |
|
Amortization of intangible assets 9 |
46.3 |
46.2 |
46.0 |
184.4 |
190.1 |
|
Tax effect of adjustments to net income and discrete tax items 10 |
(13.9) |
(6.9) |
(10.0) |
(45.3) |
(40.2) |
|
Non-GAAP net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per common share |
|
|
|
|
|
|
Effect of adjustments to net income |
|
|
|
|
|
|
Diluted non-GAAP earnings per common share |
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted averages shares outstanding |
152.5 |
151.9 |
152.3 |
152.2 |
151.8 |
|
1 Represents professional and vendor fees recorded in connection with services provided by consultants, accountants, lawyers and
other third-party service providers to assist us in integrating
2 Represents severance charges related to the integration of 3 Restructuring charges resulting from discrete cost saving initiatives inclusive of employee termination benefit and asset impairment charges, primarily related to (i) an internal reorganization, combining two complementary divisions into one and realigning our customer facing organization and (ii) workforce reductions, contract termination costs and the abandonment of certain capital equipment no longer necessary for the Company’s long-term objectives.
4 During the fourth quarter of 2024, the Company settled patent infringement litigation and received net proceeds of
5 Represents an asset reduction of an acquired tax equalization asset from the 6 Loss on extinguishment of debt in 2024 and 2025 and modification of our Existing Credit Agreement in 2024. 7 Loss (gain) from the sale of certain of the Company’s PIM and small, industrial specialty chemicals businesses. 8 Impairment of long-lived assets related to a small, industrial specialty chemicals business. 9 Non-cash amortization expense associated with intangibles acquired in acquisitions. 10 The tax effect of pre-tax adjustments to net income was calculated using the applicable marginal tax rate for each respective year. |
|||||
|
Reconciliation of Reported (In millions) (Unaudited) |
|||||
|
|
Three months ended |
Twelve months ended |
|||
|
|
|
|
|
|
|
|
Net sales |
|
|
|
|
|
|
Less: divestiture 1 |
— |
— |
— |
— |
(33.9) |
|
Adjusted net sales (excluding divestiture) Non-GAAP |
|
|
|
|
|
|
1 Adjusted to exclude net sales from the PIM business, which was divested in Q1 2024.
|
|||||
|
Reconciliation of GAAP Outlook to Non-GAAP Outlook * (In millions, except per share data) (Unaudited) |
|
|
|
First Quarter Outlook |
|
Reconciliation GAAP Operating Margin to non-GAAP Operating Margin and Adjusted EBITDA Margin |
|
|
Net sales |
|
|
GAAP - Operating income |
|
|
Operating margin - as a % of net sales |
15.7% - 17.3% |
|
Restructuring costs |
3 |
|
Amortization of intangible assets |
46 |
|
Adjusted operating income |
|
|
Adjusted operating margin - as a % of net sales |
22.0% - 23.2% |
|
Depreciation |
36 |
|
Adjusted EBITDA |
|
|
Adjusted EBITDA - as a % of net sales |
26.5% - 27.5% |
|
|
First Quarter Outlook |
|
Reconciliation GAAP net income to non-GAAP net income |
|
|
GAAP net income |
|
|
Adjustments to net income: |
|
|
Restructuring costs |
3 |
|
Amortization of intangible assets |
46 |
|
Income tax effect |
(8) |
|
Non-GAAP net income |
|
|
|
First Quarter Outlook |
|
Reconciliation GAAP diluted earnings per share to non-GAAP diluted earnings per share |
|
|
Diluted earnings per common share |
|
|
Adjustments to earnings per share: |
|
|
Restructuring costs |
0.02 |
|
Amortization of intangible assets |
0.30 |
|
Income tax effect |
(0.05) |
|
Diluted non-GAAP earnings per common share |
|
|
|
|
|
*As a result of displaying amounts in millions, rounding differences may exist in the tables. |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20260210805702/en/
Vice President, Investor Relations
T + 1 201 207 3029
jeffrey.schnell@entegris.com
Source: